Loading company…
X-Chem, Inc. provides DNA-encoded library (DEL) drug discovery services to pharmaceutical and biotech companies from Waltham, US.
Its modular HitBuilder, LeadBuilder and CandidateBuilder programs cover drug discovery from hit finding to candidate nomination. Founded in 2009 and headquartered in Waltham, US, the company was acquired by GHO Capital from PPD, Inc. in June 2020 to accelerate growth. CEOs Karen Lackey and Matthew Clark lead it, and it is recorded at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in